Birling Yoann, Nevitt Sarah, Bhuyan Deep Jyoti, Jia Mingxian, Feng Fan, Carlson Linda Ellen, Pham Tiffany, Liu Jing, Ayati Zahra, Nyiam Liyi, Yu Zhichao, Fahey Paul
NICM Health Research Institute, Western Sydney University, Penrith 2751, Australia.
Institute of Population Health, University of Liverpool, Liverpool L69 3GF, UK.
Methods Protoc. 2021 Oct 19;4(4):76. doi: 10.3390/mps4040076.
Depression, anxiety, and insomnia are common in cancer patients. Mind-body therapies (MBTs) are promising forms of treatment for cancer patients living with depression, anxiety, and insomnia. The objective of this study is to assess the effectiveness and acceptability of MBTs in cancer patients living with depression, anxiety, or insomnia. EMBase, PubMed, Cinahl, PsychINFO, IndMED, CSI-NISCAIR, CNKI, Clinicaltrial.gov, ChiCTR, and CTRI will be searched until October 2020 for relevant studies. Randomized controlled studies in which MBTs were tested in a cancer population will be selected. The authors of the selected studies will be contacted to obtain individual participant data. The participants who reached a defined clinical threshold for depression, anxiety, or insomnia will be selected for the three sub-studies on depression, anxiety, and insomnia, respectively. Pairwise and network meta-analyses will be used to assess the changes in depression, anxiety, sleep quality, and completion rate. We will assess the effect of the treatment dose (number and frequency of interventions) on effectiveness. The results of this study will inform clinical decision-making for the treatment of psychological disturbances in cancer patients. If MBTs are found effective, they will potentially be recommended as treatments for cancer patients with psychological symptoms.
抑郁症、焦虑症和失眠症在癌症患者中很常见。身心疗法(MBTs)是治疗患有抑郁症、焦虑症和失眠症的癌症患者的一种很有前景的治疗方式。本研究的目的是评估身心疗法对患有抑郁症、焦虑症或失眠症的癌症患者的有效性和可接受性。将检索EMBase、PubMed、Cinahl、PsychINFO、IndMED、CSI-NISCAIR、中国知网、Clinicaltrial.gov、中国临床试验注册中心(ChiCTR)和印度临床试验注册中心(CTRI),直至2020年10月以查找相关研究。将选取在癌症人群中对身心疗法进行测试的随机对照研究。将联系所选研究的作者以获取个体参与者数据。达到抑郁症、焦虑症或失眠症既定临床阈值的参与者将分别入选关于抑郁症、焦虑症和失眠症的三项子研究。将采用成对和网状荟萃分析来评估抑郁、焦虑、睡眠质量和完成率的变化。我们将评估治疗剂量(干预的次数和频率)对有效性的影响。本研究的结果将为癌症患者心理障碍治疗的临床决策提供依据。如果发现身心疗法有效,它们可能会被推荐作为有心理症状的癌症患者的治疗方法。